XTL Biopharmaceuticals Ltd

NAS:XTLBHealthcarenasdaq_composite

$1.97+5.35%LiveIn session · ≈ AED 7.23 · Market cap —

XTLB · Balance sheet · TradingHolo

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	3.6	3.0	2.1	1.4	0.4	0.1	−79.5%
Cash & short-term investments	6.0	6.1	3.7	2.0	1.1	0.1	−87.4%
Receivables	0.0	0.1	0.1	0.0	0.1	0.0	−100.0%
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	—
Total current assets	6.1	6.2	3.8	2.0	1.3	0.2	−87.6%
Property, plant & equipment	0.0	0.0	0.0	0.0	0.2	0.0	−100.0%
Goodwill & intangibles	0.4	0.4	0.4	0.4	7.0	0.0	−100.0%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Total assets	6.5	6.6	4.2	2.4	8.6	0.2	−98.1%
Payables	0.0	0.0	0.0	0.0	0.2	0.0	−89.8%
Short-term debt	0.0	0.0	0.0	0.0	0.1	0.3	+94.9%
Total current liabilities	0.3	0.2	0.2	0.2	2.2	0.4	−81.0%
Long-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total debt	0.0	0.0	0.0	0.0	0.1	0.3	+94.9%
Net debt	(3.6)	(3.0)	(2.1)	(1.4)	(0.2)	0.2	+182.8%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Total liabilities	0.3	1.3	0.2	0.2	3.1	0.4	−86.5%
Total equity	3.6	5.3	4.0	2.2	5.4	(0.3)	−104.7%
Retained earnings	(155.6)	(155.1)	(156.5)	(158.2)	(159.0)	(165.6)	−4.2%

USD millionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.